EcoDrugPlus

Endothelin Receptor Type B

Ensembl ID : ENSUAMG00000021633
Gene Symbol: EDNRB
2 Cross references
264 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSUAMG00000022208
Gene Symbol: EZH2
2 Cross references
222 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSUAMG00000009400
Gene Symbol: ERBB2
2 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSUAMG00000010865
Gene Symbol: ERBB3
2 Cross references
282 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSUAMG00000005438
Gene Symbol: ESR1
2 Cross references
210 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSUAMG00000018231
Gene Symbol: ESRRG
2 Cross references
277 Possible Orthologues:

Exportin 1

Ensembl ID : ENSUAMG00000026512
Gene Symbol: XPO1
2 Cross references
304 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSUAMG00000020516
Gene Symbol: FDPS
2 Cross references
263 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSUAMG00000007644
Gene Symbol: FDFT1
2 Cross references
215 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSUAMG00000027630
Gene Symbol: FNTA
2 Cross references
215 Possible Orthologues:

Fatty Acid Amide Hydrolase

Ensembl ID : ENSUAMG00000003759
Gene Symbol: FAAH
2 Cross references
131 Possible Orthologues:

Fibroblast Activation Protein Alpha

Ensembl ID : ENSUAMG00000015773
Gene Symbol: FAP
2 Cross references
127 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).